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Introduction
Vertebrates express at least 25 chondroitin sulfate proteogly-
cans (CSPGs), distinguished by the primary sequence of their 
core protein (Olson and Esko, 2004). Major groups include 
the aggrecan family of large, highly glycosylated proteogly-
cans present in connective tissues, the small leucine-rich 
 proteoglycans, collagen α2IX, basement membrane proteo-
glycans (e.g., leprecan and perlecan), membrane bound pro-
teoglycans (e.g., CD44, NG2, and phosphacan), and hybrid 
proteoglycans containing both chondroitin sulfate and hepa-
ran sulfate (syndecans). Secreted CSPGs create a hydrated 
matrix allowing for tissue expansion, and in cartilage they 
confer the ability to absorb compressive loading. In other tis-
sues, they bind and help organize fi brillar collagens and can 
affect growth factor signaling pathways. Mutations affecting 
the core proteins or the enzymes involved in the assembly of 
the chondroitin chains result in developmental abnormalities 
in skin, cartilage, bone, tendon, eyes, brain, and the microvas-
culature (Iozzo, 1998; Hassell et al., 2002; Schwartz and 
Domowicz, 2002; Ozerdem and Stallcup, 2004; Schwartz 
and Domowicz, 2004; Goldberg et al., 2005; Marneros and 
Olsen, 2005; Niisato et al., 2005).
Each chondroitin proteoglycan (CPG) consists of a protein 
core and one or more covalently attached chondroitin chains. 
Assembly occurs in a stepwise manner, starting in the endoplas-
mic reticulum with translation of core proteins on membrane 
bound ribosomes and transfer of xylose to specifi c serine residues. 
 Xylosylation exhibits specifi city, occurring only at serine residues 
that have an adjacent glycine to the COOH-terminal side and 
one or more fl anking acidic residues usually within eight amino 
acids (Esko and Selleck, 2002). After xylosylation, synthesis 
of a tetrasaccharide primer (-GlcAβ3Galβ3Galβ4Xylβ-O-Ser) 
takes place in the Golgi, followed by the polymerization of 
the chain by the alternating addition of N-acetylgalactosamine 
(GalNAc) and glucuronic acid (GlcA; [GlcAβ3GalNAcβ4]n; 
Sugahara et al., 2003). In vertebrates, the chains undergo 
further modifi cation by the addition of sulfate at C4 and 
C6 of GalNAc and C2 of GlcA residues (Habuchi, 2000). 
Additionally, an epimerase can convert a subset of GlcA resi-
dues to l-iduronic acid, which can be subsequently sulfated 
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Vertebrates produce multiple chondroitin sulfate proteoglycans that play important roles in devel-opment and tissue mechanics. In the nematode 
Caenorhabditis elegans, the chondroitin chains lack sul-
fate but nevertheless play essential roles in embryonic de-
velopment and vulval morphogenesis. However, assignment 
of these functions to specifi c proteoglycans has been lim-
ited by the lack of identifi ed core proteins. We used a 
combination of biochemical purifi cation, Western blotting, 
and mass spectrometry to identify nine C. elegans chon-
droitin proteoglycan core proteins, none of which have 
homologues in vertebrates or other invertebrates such as 
Drosophila melanogaster or Hydra vulgaris. CPG-1/CEJ-1 
and CPG-2 are expressed during embryonic development 
and bind chitin, suggesting a structural role in the egg. 
RNA interference (RNAi) depletion of individual CPGs 
had no effect on embryonic viability, but simultaneous 
 depletion of CPG-1/CEJ-1 and CPG-2 resulted in multi-
nucleated single-cell embryos. This embryonic lethality 
phenocopies RNAi depletion of the SQV-5 chondroitin 
synthase, suggesting that chondroitin chains on these two 
proteoglycans are required for cytokinesis.
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as well (dermatan  sulfate). The pattern of sulfation varies in 
different tissues during development and in relation to age.
Interestingly, very little is known about the proteogly-
cans present in invertebrates, even in the well-studied nematode 
Caenorhabditis elegans. All of the components of the chondroitin 
biosynthetic machinery are completely conserved between 
C. elegans, mice, and humans, including formation of nucleotide 
sugar precursors and their import into the Golgi, assembly 
of the linkage region, and polymerization of the chain (Bulik 
et al., 2000; Berninsone et al., 2001; Hwang and Horvitz, 
2002a,b; Yamada et al., 2002; Hwang et al., 2003a,b; Izumikawa 
et al., 2004). However, C. elegans lacks the sulfotransferases 
and the epimerase present in vertebrates, so the chains consist 
of unmodifi ed GalNAc and GlcA residues (Yamada et al., 1999; 
Toyoda et al., 2000). In spite of its simplicity, genetic experi-
ments demonstrate a crucial role for chondroitin in embryonic 
cell division and vulval morphogenesis (Herman et al., 1999; 
Bulik and Robbins, 2002; Hwang and Horvitz, 2002a,b; Hwang 
et al., 2003a,b; Mizuguchi et al., 2003; Izumikawa et al., 2004).
Although all of the enzymes required for chondroitin syn-
thesis have been identifi ed in C. elegans, no protein cores that 
bear the chondroitin chains have been described. To identify 
CPGs in C. elegans, we conducted searches using BLAST 
 (Basic Local Alignment Search Tool) with all known mammalian 
CSPG core protein sequences but did not identify any obvious 
homologues. We therefore pursued a proteomics-based ap-
proach taking advantage of the chemical properties of the long, 
negatively charged chondroitin chains, a tagging method to 
modify the serine attachment sites, and mass spectrometry. We 
report the discovery of nine novel CPG proteins, none of which 
show homology to vertebrate CSPGs. Simultaneous depletion 
of two of these proteins, CPG-1/CEJ-1 and CPG-2, by RNAi 
results in defective cytokinesis during the fi rst embryonic cell 
division. This phenotype is identical to that observed when the 
sqv-5 chondroitin synthase was silenced by RNAi or by a loss-of-
function mutation (Herman et al., 1999; Hwang and Horvitz, 
2002b; Hwang et al., 2003b; Mizuguchi et al., 2003), suggesting 
that these two major chondroitin-carrying proteoglycans are 
 essential for embryonic development.
Results
C. elegans expresses multiple CPGs
Proteoglycans were solubilized from a mixed-stage worm pop-
ulation by a combination of sonication and extraction with gua-
nidine hydrochloride. After dialyzing the crude extract into 
urea, the proteoglycans were partially purifi ed by stepwise elu-
tion from an anion-exchange column, using 0.2 M NaCl with 
urea to remove contaminating proteins and 1 M NaCl without 
urea to elute the proteoglycans (see Materials and methods). 
Treatment of the sample with sodium hydroxide released the 
chains from their core proteins by β-elimination reaction. The 
liberated chondroitin chains were generally <20 kD based on 
their elution by gel fi ltration chromatography relative to shark 
cartilage chondroitin sulfate (Fig. 1 A; Yamada et al., 1999), but 
they exhibited considerable heterogeneity. Treatment of the 
sample with chondroitinase ABC converted all of the material 
into nonsulfated disaccharides that eluted near the total volume 
of the column, confi rming that the preparation contains pre-
dominantly chondroitin and very little heparan sulfate (Yamada 
et al., 1999; Toyoda et al., 2000).
To estimate the number of CPGs, the crude C. elegans 
proteoglycans were digested with chondroitinase ABC, sepa-
rated by SDS-PAGE, and analyzed by Western blotting with the 
1B5 mAb that recognizes a neoepitope generated by chondroi-
tinase digestion (Fig. 1 B). Several CPG core proteins ranging 
in mass from 10 to >200 kD were detected in whole worm 
(lanes 2 and 3) and embryo extracts (lane 4), whereas none were 
detected if chondroitinase ABC was omitted (lane 1). The major 
species had masses of 118, 110, and 60 kD. Treatment of 
samples with PNGase F had no effect on the mobility of these 
bands, suggesting that none of the proteins contained Asn-linked 
glycans (unpublished data). C. elegans also synthesizes at least 
three heparan sulfate–bearing proteoglycans with approximate 
masses of 45, 28, and 22 kD based on digestion of extracts 
with heparinase followed by Western blotting with 3G10 mAb, 
which is specifi c for a heparan sulfate neoepitope generated by 
enzyme digestion (Hwang et al., 2003b). In vertebrates, some 
proteoglycans contain both chondroitin sulfate and heparan sul-
fate chains (e.g., syndecans 1 and 3). Simultaneous digestion of 
samples with chondroitinase ABC and heparin lyase II did not 
alter the intensity of any of the CPG bands or give rise to new 
ones reactive with mAb 1B5 or 3G10 (unpublished data). Thus, 
hybrid proteoglycans might not exist in C. elegans.
To identify the CPG core proteins detected by Western 
blotting, we searched the C. elegans genome for sequences re-
lated to any of the 25 known mammalian CSPG core proteins 
(Olson and Esko, 2004). No obvious homologues were found, 
with the exception of ORF Y47D3A.26, which resembled 
bamacan/SMC3 (Wu and Couchman, 1997). However, the cod-
ing sequence for this gene, as well as vertebrate bamacan, lacks 
Figure 1. C. elegans express multiple CPGs. (A) Glycopeptides were 
treated with alkali to produce free glycans, which were then analyzed by 
gel fi ltration HPLC (see Materials and methods). Untreated sample eluted 
as two peaks (indicated by squares), whereas after chondroitinase ABC all 
the material eluted as disaccharides (indicated by circles). Vi, elution posi-
tion of [1-3H]glucose; Vo, elution position of blue dextran. Shark cartilage 
chondroitin sulfate (20 kD) was run as a standard. (B) Crude extracts of 
adult worms (lanes 1–3) or embryos (lane 4) were digested with chondroi-
tinase ABC (lanes 2–4) and separated by SDS-PAGE. Western blotting was 
performed with mAb 1-B-5, which recognizes a neoepitope generated by 
chondroitinase digestion. The undigested control (lane 1) demonstrates the 
requirement of the antibody for chondroitin stubs. Lanes 2 and 4, 10-μg 
protein; lanes 1 and 3, 40-μg protein. The carats indicate the position of 
protein bands that arose only after chondroitinase ABC digestion.
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a signal peptide present in all known proteoglycans, consistent 
with the observation that most of bamacan is found in the nu-
cleus in a nonglycosylated form (Ghiselli and Iozzo, 2000). 
Thus, a new method was needed to identify the various CPGs 
in C. elegans.
Fig. 2 describes the scheme used to identify C. elegans 
CPGs. After the DEAE chromatography step, samples were re-
duced, alkylated, and digested with trypsin. Peptides containing 
chondroitin chains (glycopeptides) were recovered by a second 
round of anion-exchange chromatography, which removed 
much of the contaminating protein from the sample. In some 
experiments, we used gel fi ltration to separate glycopeptides of 
large hydrodynamic size from contaminating peptides rich in 
acidic amino acids, which coeluted under the low salt condi-
tions used to prepare the samples. Next, the samples were 
treated with sodium hydroxide, which caused β-elimination of 
the chains and the formation of dehydroalanine from serine 
 residues. The dehydroalanine residues were then reacted with 
DTT, which adds across the double bond (Wells et al., 2002). 
In some experiments, the DTT-tagged peptides were further 
 purifi ed with a thiol column. Samples were then analyzed by 
mass spectrometry using multidimensional protein identifi ca-
tion technology (MUDPIT) to identify peptides containing DTT 
(+167 D) or dehydroalanine (−18 D; Washburn et al., 2001; 
Wolters et al., 2001). The corresponding full-length proteins 
were identifi ed by searching a C. elegans proteome database, 
parsing the data using the following criteria: (1) putative CPGs 
had to contain at least one glycosaminoglycan attachment site, 
defi ned as a modifi ed serine residue fl anked on the COOH-
 terminal side by glycine with one or more aspartate or glutamate 
residues near the site of chondroitin addition (Esko and Zhang, 
1996), and (2) the proteins had to have a hydrophobic signal 
peptide, which would direct the protein into the secretory path-
way, where chondroitin synthesis occurs. Nine tentative CPG 
core proteins were identifi ed by this procedure and designated 
CPG-1 through -9 (Fig. 3).
Characteristics of the C. elegans CPGs
CPG-1 (C07G2.1a) and CPG-2 (B0280.5) have predicted 
masses of 62 and 54 kD, respectively (Fig. 3). CPG-1 was iden-
tifi ed previously as CEJ-1 based on its reactivity with an anti-
body to a mammalian tight junction protein (Siddiqui, S.S., 
personal communication). It contains fi ve putative chondroitin 
attachment sites based on amino acid sequence. One of these 
sites was confi rmed by mass spectrometry based on presence 
of the DTT tag. In contrast, CPG-2 has 34 potential chondroitin 
attachment sites (four confi rmed by mass spectrometry; Fig. 3). 
CPG-1 and -2 also have in common multiple peritrophin-A 
chitin binding motifs, defi ned by the arrangement of six cysteine 
Figure 2. Scheme for identifying CPGs in C. elegans.
Figure 3. C. elegans CPGs identifi ed by 
BEMAD/MUDPIT. CPGs were purifi ed from worm 
extracts and identifi ed by mass spectrometry 
analysis. Nine independent purifi cations re-
sulted in identifi cation of nine CPGs, most of 
which were identifi ed in multiple runs. The pre-
dicted masses are based on amino acid se-
quence, and the apparent masses are based 
on SDS-PAGE migration of recombinant pro-
teins expressed in COS-7 cells after digestion 
with chondroitinase ABC and reduction. Puta-
tive glycosylation sites (short vertical lines) con-
sist of Ser-Gly dipeptides fl anked by one or 
more acidic amino acids. Identifi ed sites (long 
vertical lines) represent serine residues modi-
fi ed with DTT by the BEMAD method (see 
 Materials and methods). Genes enriched for 
germline expression were identifi ed by Reinke 
et al. (2000). Schematic drawings of each 
CPG are shown. Gray circles indicate signal 
peptides, black ovals are peritrophin-A chitin 
binding domains, diagonally hatched boxes 
identify C-type lectin domains, and dotted lines 
below the protein indicate peptide coverage 
discovered by mass spectrometry.
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residues that can form three disulfi de bridges in a characteristic 
pattern (Wright et al., 1991; Beintema, 1994; Venegas et al., 1996;
Merzendorfer and Zimoch, 2003). In CPG-1, two peritrophin-A 
domains lie in the NH2-terminal half of the protein and one 
 toward the COOH-terminal end, whereas in CPG-2 the six 
peritrophin-A domains lie between sites predicted to be gly-
cosylated (Fig. 3). Additionally, the COOH-terminal half of 
CPG-1 contains many Thr, Val, and Pro residues, resembling a 
segment of Muc-2, a membrane mucin present in vertebrates.
CPG-3 (R06C7.4) was not originally identifi ed by the 
DTT-tagging method or by the presence of dehydroalanine 
(Wells et al., 2002) but rather by 5′-RACE using PCR primers 
designed against the repetitive SG region of cpg-2. Reevalua-
tion of the mass spectral data revealed that peptides from CPG-3 
were present in nearly all datasets (Fig. 3). Based on primary 
sequence, CPG-3 contains 15 putative chondroitin attachment 
sites and shows 21% sequence identity to CPG-2, mainly in the 
putative glycosylated region. The lack of mass spectral data for 
peptides that contain putative attachment sites in CPG-3 may 
have been caused by the failure of trypsin to gain access to and 
cleave the protein in heavily glycosylated regions.
CPG-4 (C10F3.1) has the largest predicted mass of the 
C. elegans CPGs at 84 kD. The majority of its 35 predicted gly-
cosaminoglycan attachment sites reside in the COOH-terminal 
half of the protein, of which four sites were confi rmed by DTT 
modifi cation (Fig. 3).
CPG-5 (C25A1.8, CLEC-87) and CPG-6 (K10B2.3a, 
CLEC-88) are highly homologous, showing 67% identity and 
90% similarity. CPG-5 and -6 contain only one putative chon-
droitin site toward the NH2 terminus, which was identifi ed in 
both proteins by DTT modifi cation. Both proteins contain a 
C-type lectin domain in the COOH-terminal half of the protein, 
like the aggrecan family of vertebrate CSPGs (Zelensky and 
Gready, 2003). This motif therefore classifi es cpg-5 and -6 as 
members of the clec (C-type lectin) gene class. Proteins con-
taining C-type lectins are common in C. elegans (88 members 
have been found thus far), but their glycan binding specifi city 
has not been determined.
CPG-7 (K09E4.6) and CPG-8 (K03B4.7a) have predicted 
masses of only 12 kD (Fig. 3). CPG-7 contains 11 putative 
chondroitin attachment sites, whereas CPG-8 contains 6 sites. 
In both cases, fi ve of the sites were confi rmed by mass 
 spectrometry. Of the multiple peptides identifi ed in CPG-8 sam-
ples, some contained a single modifi ed site at either residue 61 
or 63 (the tandem mass spectrometry data did not discriminate 
which site actually carried the chain). Interestingly, other 
 peptides were modifi ed at both serine residues. A similar phe-
nomenon was observed at residues 84 and 88. CPG-9 (Y67D8C.8)
has a predicted mass of only 7 kD, and mass spectrometry con-
fi rmed two of four attachment sites.
Interestingly, none of the CPGs identifi ed using the 
scheme in Fig. 2 showed homology to vertebrate CSPGs. 
 Furthermore, no homologues were found in searches of the 
D. melanogaster genome or Hydra vulgaris EST and genomic 
databases, suggesting that the core proteins have evolved in-
dependently in different organisms. In contrast, homologues for 
each C. elegans CPG were present in Caenorhabditis briggsae, 
another free-living nematode.
The glycosylation sites of many C. elegans CPGs ap-
peared to follow an “SGEX” motif, where X was usually G, A, 
T, or S (Fig. 4). BLAST searches using this sequence motif 
identifi ed CPG-2, -3, -4, and -7 but no other proteins in 
C. elegans or vertebrates. D. melanogaster contains one protein 
containing this motif (CG6048-PA), but it has not yet been shown 
to contain a chondroitin chain. The aggrecan family of CSPGs in 
vertebrates also contains repetitive SG sequences within domains 
densely substituted with chondroitin chains, but the intervening 
sequences differ from those found in C. elegans CPGs.
C. elegans core proteins carry chondroitin 
sulfate chains after expression 
in mammalian cells
To confi rm that the C. elegans CPGs identifi ed by mass spectrom-
etry could serve as a scaffold for chondroitin synthesis, the cDNA 
sequences were subcloned into a mammalian expression vector 
with a COOH-terminal Myc tag and expressed in COS-7 cells. 
Figure 4. Chondroitin attachment sites in 
CPGs. Primary sequences of CPG peptide seg-
ments containing chondroitin attachment sites 
are shown using the single letter code for each 
amino acid. Underlined SG dipeptides refer 
to attachment sites in which the serine resi-
dues were modifi ed by DTT or converted to 
 dehydroalanine residues during BEMAD.
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Conditioned media was collected 48 h after transfection, 
purifi ed by anion-exchange chromatography, treated with chon-
droitinase ABC, and Western blotted with an antibody to Myc 
(Fig. 5). CPG1-6 yielded reactive protein bands that did not ap-
pear in the absence of chondroitinase ABC digestion. Attempts 
to express CPG7-9 in COS cells have thus far been unsuccessful, 
possibly because of the small size of the protein core. None of 
the proteoglycans migrated at the molecular mass predicted by 
their primary sequence. Furthermore, a comparison of the bands 
in Fig. 1 B to the calculated masses in Fig. 3 did not dem onstrate 
obvious correspondence. However, the migration pattern of 
CPG-2 expressed in COS cells appears similar to the 120-kD 
core in the crude proteoglycan preparation (Fig. 1 B). Likewise, 
CPG-3 migrates at 55–60 kD, the same position as a prevalent 
band in the worm extract. These observations suggest the pre-
sence of higher order structures in the core proteins or that the 
chondroitin stub oligosaccharides remaining after chondroitinase 
digestion altered their migration. Mammalian CSPGs also 
tend to migrate aberrantly, often at twice their predicted size 
(Bellin et al., 2002).
Simultaneous RNAi of cpg-1 and -2 leads 
to penetrant embryonic lethality
Expression of cpg-1, -2, -3, -5, and -6 is enriched in the 
C. elegans germline, suggesting possible activity in germline 
development and progression, spermatogenesis, oogenesis, or 
embryogenesis (Reinke et al., 2000; Fig. 3). However, genome-
wide RNAi screens have not reported phenotypes for any of the 
cpg genes, suggesting either functional redundancy or subtle 
phenotypes (www.wormbase.org). Lee and Schedl (2001) re-
ported that GLD-1 acts as a translational repressor of several 
mRNA targets in the germline, including cej-1 and B0280.5, 
which were identifi ed in our proteomic screen as cpg-1 and -2, 
respectively. They also reported that RNAi of each gene alone 
had no phenotype, whereas simultaneous depletion of both 
genes resulted in embryonic lethality. Because this phenotype 
is reminiscent of the embryonic phenotype resulting from in-
hibiting the SQV-5 chondroitin synthase, we decided to analyze 
CPG-1 and -2 in greater detail.
To confi rm that CPG-1 and -2 contain chondroitin chains 
in vivo, worms were fed bacteria expressing double-stranded 
RNA (dsRNA) directed against cpg-1 or -2, and samples were 
analyzed by Western blotting. No differences were initially 
 observed in CPG-1–depleted extracts (Fig. 6 A), but CPG-2–
 depleted extracts showed a dramatic reduction of the major band 
at 120 kD, as well as the bands at 80 and 45 kD (Fig. 6 A, 
arrowheads), suggesting that all three were related to each 
other (the predicted mass of the protein was 54 kD; Fig. 3). The 
 simultaneous reduction of these three bands was confi rmed by 
using a second construct targeting a different region of cpg-2 
(unpublished data). The RNAi effect was specifi c, as the other 
major core protein band at 60 kD remained unaltered.
CPG-1 and -2 have in common multiple peritrophin-A 
chitin binding domains (Fig. 3). To test the functionality of 
these domains, crude worm extract was incubated with chitin 
beads. Four CPG bands were able to bind chitin, including those 
at 120, 80, and 45 kD (Fig. 6 B, fi lled arrowheads), as well as 
a new band at 150 kD (Fig. 6 B, open arrowhead). Chitin 
binding appeared to be selective, as the major band at 60 kD did 
not interact with the resin. cpg-2 RNAi treatment diminished the 
three bands at 120, 80, and 45 kD, confi rming the presence 
and functionality of one or more peritrophin-A chitin binding 
domains in these proteoglycans (Fig. 6 C, fi lled arrowheads). 
The band migrating at 150 kD was present in vector and CPG-2–
depleted extracts but absent in extracts depleted of CPG-1 
and CPG-1/CPG-2 (Fig. 6 C, open arrowhead). Recombinant 
CPG-1 expressed in COS-7 cells had a similar mass (Fig. 5), 
suggesting the 150-kD band represents CPG-1. Thus, both 
CPG-1 and -2 behave as CPGs in vivo and have functional 
 chitin binding domains.
To study the function of CPG-1 and -2, we compared the 
effect of silencing their expression by RNAi to depletion of 
SQV-5, which encodes the chondroitin synthase. Brood sizes 
of cpg-1(RNAi), cpg-2(RNAi), and cpg-1/cpg-2(RNAi) animals 
were comparable to uninjected worms or worms injected with 
Figure 5. CPG-1 through -6 behave as CSPGs in COS-7 cells. CPG-1 
through -6 were expressed as Myc-tagged recombinant proteins in COS-7 
cells. Proteoglycans from conditioned media were purifi ed by anion-
 exchange chromatography (see Materials and Methods). Samples were 
digested with chondroitinase ABC (+) or left untreated (−), separated by 
SDS-PAGE, and Western blotted with an anti-Myc mAb.
Figure 6. CPG-1 and -2 bind chitin and exist as CPGs in vivo. (A) Proteo-
glycan extracts of vector and RNAi-treated animals were digested with 
chondroitinase ABC, analyzed by SDS-PAGE, and Western blotted with the 
1B5 mAb that recognizes the chondroitin stub remaining after enzyme 
 digestion. cpg-2(RNAi) reduced the bands at 120, 80, and 45 kD 
 (arrowheads). (B) 20 μg of total worm extract (input) was incubated with 
chitin beads. Four bands specifi cally bound chitin (arrowheads), but the 
60-kD band did not. (C) Proteoglycan extracts from RNAi-treated animals 
were enriched by affi nity chromatography on chitin beads. cpg-1(RNAi) 
reduced the band at 150 kD (open arrowhead), whereas cpg-2(RNAi) 
reduced the bands at 120, 80, and 45 kD (fi lled arrowheads).
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buffer alone (Table I; P > 0.05 by one-way analysis of 
variance). Depletion of CPG-1 or -2 alone also had no effect on 
viability, as 96–99% of the embryos hatched into healthy lar-
vae that grew into normal fertile adults (Table I). However, 
 simultaneous depletion of CPG-1 and -2 had a synergistic 
 effect, resulting in penetrant embryonic lethality. Whether this 
 synergy is due to the functional redundancy of CPG-1 and -2, 
the  partially penetrant nature of RNAi, other functions of the 
 proteoglycans besides carrying chondroitin chain, or the cross-
 reactivity of cpg-2 dsRNA with other targets remains to be 
 determined. sqv-5(RNAi) treatment also had no effect on egg 
production or laying but had a hatching phenotype similar to 
cpg-1/cpg-2(RNAi) (95% of progeny failed to hatch). To look 
for genetic interactions between sqv-5 and cpg-1 or -2, a 
 heterozygous sqv-5(n3611) mutation was compounded with 
single cpg-1(RNAi) or cpg-2(RNAi). However, no combination 
affected brood sizes or embryonic viability (unpublished data), 
possibly because the heterozygous mutation did not reduce 
chondroitin levels suffi ciently to see the effect of depleting a 
single CPG.
RNAi of cpg-1 and -2 results 
in a cytokinesis defect
To determine the underlying cause for embryonic lethality, 
we looked more closely at the fi rst cell division, where de-
fects have been reported in sqv-5 chondroitin synthase mutants 
(Hwang et al., 2003b). To better visualize the plasma mem-
brane, a strain expressing GFP fused to a pleckstrin homology 
(PH) domain derived from mammalian phospholipase-C was 
injected with dsRNA against cpg-1, cpg-2, cpg-1/cpg-2, or 
sqv-5. The PLC1δ1 PH domain binds to phosphatidylinositol 
4,5 bisphosphate located specifi cally on the plasma membrane 
and is an excellent probe for monitoring the changes in cell 
shape that accompany cytokinesis (Audhya et al., 2005). The 
depleted embryos were simultaneously imaged by differential 
interference contrast (DIC; Fig. 7, top) and spinning-disc con-
focal microscopy (Fig. 7, bottom). Embryos were imaged in 
utero because depletion of either SQV-5 or both CPG-1 and -2 
resulted in embryos that were fragile and osmotically sensitive. 
Depletion of CPG-1 or -2 alone had no effect on fertilization, 
membrane ruffl ing, pseudocleavage, pronuclear meeting and 
rotation, karyokinesis, and cytokinesis (compare Video 2 to buffer-
injected worms in Video 1, available at http://www.jcb.org/cgi/
content/full/jcb.200603003/DC1). Initiation of the cleavage 
furrow occurred normally (Fig. 7 D, bottom), and two sepa-
rate daughter cells routinely appeared (Fig. 7 E). A four-celled 
embryo was distinctly seen at the end of fi lming, demonstrating 
the fi delity of the second round of cell division (Fig. 7 G). 
In contrast, embryonic development was severely perturbed in 
embryos simultaneously depleted of CPG-1 and -2 (Video 3). 
In wild-type embryos, fertilization triggers the oocyte pronu-
cleus to undergo two rounds of meiotic segregation, which pro-
duces two polar bodies that are extruded from the embryo by 
small cytokinesis-like events. In CPG-1/CPG-2–depleted em-
bryos, fertilization occurred normally but polar body extrusion 
failed, resulting in extra nuclear material that remained in the 
embryo (Fig. 7, I and J). The pronuclei migrated and the com-
plex of the pronuclei and centrosomes rotated onto the long 
axis of the cell as in wild type, but the membrane ruffl ing that 
normally precedes and accompanies these events was absent, 
as was the space between the embryonic plasma membrane 
and the eggshell that is normally present during cell division 
(compare Fig. 7, C [bracket] and J [solid white lines]). Spindle 
formation appeared normal and the chromosomes appeared to 
segregate, but the cleavage furrow failed to form and ingress 
to introduce a new cell surface between the segregated chro-
mosomes (Fig. 7, K and L). Without the barrier of a new cell 
membrane, the daughter nuclei fused (Fig. 7 M) and repeatedly 
attempted cell division without cytokinesis (Fig.7 N). An es-
sentially identical phenotype was observed after depletion of 
SQV-5 (Fig. 7, O–U; and Video 4). Since depleting CPG-1 and -2 
mimics the defect in embryonic cytokinesis by depletion of 
the SQV-5 chondroitin synthase, we conclude that CPG-1 and 
-2 are two functionally important CPGs required at this early 
 developmental stage.
Discussion
A proteomic approach for identifying 
novel proteoglycans
We report here the identifi cation of a group of novel CPGs in 
C. elegans. The identifi cation scheme used a combination of con-
ventional methods to purify proteoglycans and glycopeptides 
based on the polyanionic character and size of the chondroitin 
chains coupled with mass spectrometry. Additional selection 
criteria ensured that the majority of identifi ed proteins had the 
properties of a proteoglycan. These included chondroitin 
 attachment sites modifi ed with DTT, the presence of a serine 
residue followed by glycine and one or more nearby acidic 
 residues, and a signal peptide. Although DTT addition was not 
stoichiometric, the β-elimination step introduced an alternate 
method to identify the protein via the characteristic mass dif-
ference between dehydroalanine and serine (Wells et al., 2002). 
Attempts to optimize the DTT-addition reaction have not yet 
yielded higher effi ciency, and other methods are needed to im-
prove this step to better assess the stoichiometry of chondroitin 
attachment. Similarly, adjustment of the proteolysis conditions 
might improve peptide coverage, as the absence of trypsin 
Table I. Brood size and viability in RNAi-treated worms
RNAi treatment Brood sizea Range Viability
%
Uninjected 133 ± 43 75–197 98.9
Buffer 120 ± 45 65–178 99.6
cpg-1 95 ± 34 64–184 95.9
cpg-2 144 ± 42 87–202 99.2
cpg-1/cpg-2 129 ± 56 62–203 0.0
sqv-5 77 ± 22 22–114 4.8
The number of embryos and hatched L1 larvae were assessed 24 h after 
placing control worms or worms injected with dsRNA on individual plates. 
Viability was determined >24 h after the initial brood size was counted and 
was calculated as the number of hatched larvae divided by the total number 
of embryos laid. n = 6–11.
aOne-way analysis of variance showed no signifi cant difference between brood 
sizes. P > 0.05.
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cleavage sites and the potential inhibitory effects of closely 
spaced chondroitin chains could interfere with the analysis. 
 Regardless of its limitations, the current protocol led to the iden-
tifi cation of nine proteins that had the hallmarks of CPGs, and 
six served as substrates for chondroitin sulfate assembly when 
expressed in mammalian cells. The simplicity of the identifi ca-
tion strategy suggests that it should be generally applicable to 
other organisms, as well as tissues, cells, and secretions from 
vertebrates for which little information about the proteoglycan 
composition exists.
Interestingly, none of the C. elegans CPGs identifi ed in 
this study had predicted membrane spanning domains or con-
sensus sites for glycosphosphatidylinositol-anchor attachment. 
C. elegans expresses homologues of the membrane heparan 
 sulfate proteoglycan syndecan, which has a single membrane 
spanning segment, and the glycosphosphatidylinositol-anchored 
heparan sulfate proteoglycan, glypican. Because vertebrates ex-
press multiple membrane CSPGs (e.g., NG2, CD44, and phos-
phacan; Olson and Esko, 2004), our failure to identify membrane 
CPGs in C. elegans could indicate either their absence or that 
they represent only minor components of the proteoglycan 
 population. Heparan sulfate proteoglycans also were not detected, 
most likely because C. elegans expresses 250 times less hepa-
ran sulfate than chondroitin (Yamada et al., 1999; Toyoda et al., 
2000). Thus, it may be necessary to modify the procedure to se-
lectively enrich membrane proteins and increase sample size to 
detect rare proteoglycans.
The lack of homology between C. elegans CPGs and ver-
tebrate CSPGs and the observation that none of the CPGs have 
homologues in two other invertebrates (D. melanogaster and 
H. vulgaris) raises interesting questions about the evolution of 
these molecules. All of the core proteins identifi ed in this study 
have sequence motifs required for initiation of glycosamino-
glycan biosynthesis similar to those found in vertebrates (Esko 
and Zhang, 1996). Furthermore, C. elegans expresses orthologues 
of all of the vertebrate enzymes required for assembly of the 
linkage region tetrasaccharide (xylosyltransferase, galactosyl-
transferases I and II, and glucuronyltransferase I; Bulik et al., 
2000; Hwang et al., 2003a), as well as the chondroitin polymer-
izing system (Hwang et al., 2003b; Mizuguchi et al., 2003), in-
cluding the newly discovered chondroitin polymerizing factor 
(Izumikawa et al., 2004). These fi ndings indicate that the mech-
anism of chain initiation and polymerization evolved early in 
metazoans and has been maintained by strong selection. In con-
trast, the core proteins on which the chains assemble have con-
tinued to evolve, presumably to serve specialized functions. For 
example, CPG-1 and -2 have functional chitin binding domains 
that could interact with the nematode eggshell, whereas no ver-
tebrate proteoglycans contain this motif and vertebrates lack 
chitin as a structural component. The presence of chitin in 
insect exoskeletons and peritrophic matrices that line the 
gut suggests that orthologues of these CPGs might exist in 
D. melanogaster (Merzendorfer and Zimoch, 2003), but BLAST 
searches have not yet uncovered them. Additional studies using 
techniques like the one reported here are needed to identify the 
proteoglycans present in D. melanogaster and other organisms, 
which in turn might help defi ne the evolution of proteoglycans 
during the metazoan expansion.
Figure 7. CPG-1 and -2 are required for em-
bryonic cell division. The fi rst two cell divisions 
of embryos depleted of CPG-2 (A–G, see 
Video 2, anterior toward the top left, available 
at http://www.jcb.org/cgi/content/full/jcb.
200603003/DC1), CPG-1/CPG-2 (H–N, 
see Video 3, anterior toward the bottom right), 
and SQV-5 (O–U, see Video 4, anterior to-
ward the bottom right) were analyzed by DIC 
Nomarski microscopy (top) and membrane-GFP 
fl uorescence (bottom). (A, H, and O) Pseudo-
cleavage initiates in the cpg-1 single RNAi 
(open arrowheads), but not in the cpg-1/cpg-2 
double or sqv-5 RNAi embryos. The maternal 
(m) and paternal (p) pronuclei are indicated. 
(B, I, and P) Pronuclear fusion proceeds nor-
mally in single, double, and sqv-5 RNAi 
 embryos. However, extrusion of the second 
polar body fails in doubly depleted and sqv-5 
embryos (indicated by asterisks). (C, J, and Q) 
Rotation of the fused nuclei. (D, K, and R) Initia-
tion of the fi rst cell division. The cleavage fur-
row is seen in cpg-1(RNAi) embryos (black 
arrowheads). (E, L, and S) Cytokinesis is com-
plete in cpg-1(RNAi) embryos, forming two 
daughter cells. Nuclear division appears nor-
mal in cpg-1/cpg-2(RNAi) and sqv-5(RNAi) 
embryos, but cytokinesis did not initiate, caus-
ing the daughter nuclei and polar body to re-
join (M and T). Cell division is attempted again 
(N and U), resulting in multiple nuclei in a 
 single-celled embryo (white arrowheads). 
The second cell division (F and G) proceeds 
normally in cpg-1(RNAi) embryos.
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CPG-1/CEJ-1 and CPG-2 play essential 
roles in embryonic cell division in C. elegans
Our preliminary analysis of RNAi-depletion experiments indi-
cated that silencing cpg-1 or -2 had no effect on embryogenesis 
or morphogenesis. However, depletion of both genes resulted in 
a strong embryonic phenotype characterized by failure of polar 
body extrusion after fertilization, loss of membrane ruffl ing pre-
ceding pronuclear fusion, and failure to initiate the cleavage 
furrow before cytokinesis. The necessity of depleting both 
CPG-1 and -2 to uncover a phenotype suggests functional re-
dundancy of the proteins, though the only commonality is the 
presence of chitin binding domains and at least one chondroitin 
chain (Fig. 3). An alternative explanation is that depletion of 
each protein by RNAi may not have been fully penetrant, and 
the phenotype after double depletion could be the result of more 
extensive depletion of chondroitin. However, this explanation 
seems unlikely because CPG-1 is a minor component and had 
to be enriched by chitin affi nity chromatography to detect its 
presence. Instead, the requirement for simultaneous depletion 
of both proteoglycans could be due to other functional aspects 
of the CPGs (e.g., their ability to bind chitin or the presence of 
other glycans). Generation of deletion mutants will help resolve 
this issue.
The strong embryonic lethal phenotype seen with cpg-1/
cpg-2(RNAi) resembles that of the sqv-5 chondroitin synthase 
mutant described by Hwang et al. (2003b). How the CPGs me-
diate these effects is unknown. One of the roles of CPGs may be 
to fi ll the space between the eggshell and the embryo, and the 
presence of a high concentration of polyanions and their coun-
terions might cause suffi cient hydrostatic pressure to aid in for-
mation of the extraembryonic space and subsequent ingress of 
the cleavage furrow. Thus, the loss of CPGs in the perivitelline 
space surrounding the embryo could result in collapse of the 
extracellular space and apposition of the plasma membrane 
to the eggshell (Fig. 7). Interestingly, chondroitin has been 
shown to be present on both the embryonic cell surface and the 
eggshell, suggesting that it may function at both locations 
(Sugahara et al., 2003). This leads to an alternative explanation: 
CPG-1 and -2 could act as structural elements of the eggshell or 
might bridge chitin polymers in the eggshell with other compo-
nents of the embryonic plasma membrane that result in trans-
membrane signaling to cytoskeletal components involved in 
cytokinesis. Regardless of which hypothesis is correct, we have 
shown that CPG-1 and -2 play a crucial role in cytokinesis, as 
their simultaneous depletion results in multinucleated single 
cell embryos.
The observation that the regulatory protein GLD-1 may 
translationally regulate cpg-1 and -2 transcripts indicates a so-
phisticated level of control over proteoglycan expression during 
early embryogenesis. GLD-1 is localized to the germline cyto-
plasm (Jones et al., 1996) and translationally regulates the ex-
pression of a large number of genes by interacting with mRNA 
3′UTR sequences (Lee and Schedl, 2001). It also protects some 
transcripts from nonsense-mediated mRNA decay by binding 
to 5′UTR sequences (Lee and Schedl, 2004). One example is 
gna-2, which encodes the enzyme glucosamine 6-phosphate 
N-acetyltransferase. This enzyme plays an essential role in the 
biosynthesis of the nucleotide sugar UDP-N-acetylglucosamine 
(UDP-GlcNAc). The biosynthesis of a variety of glycans depends 
on UDP-GlcNAc, including chitin (a polymer of GlcNAcβ1,4) 
and chondroitin by way of UDP-GalNAc. Interestingly, a null 
allele of gna-2(qa705) exhibits maternal effect lethality and 
multinucleated embryos (Johnston, W., and Dennis, J., personal 
communication). The similar phenotype of cpg-1/cpg-2(RNAi), 
sqv-5(RNAi), and gna-2 mutants may indicate a common mecha-
nism of action through formation of CPGs. Posttranscriptional 
regulation of CPG assembly in C. elegans via GLD-1 is reminis-
cent of the regulation of enzymes involved in heparan sulfate for-
mation in vertebrates (Grobe and Esko, 2002) and may indicate 
the general importance of translational control over proteoglycan 
assembly during development.
Materials and methods
C. elegans maintenance
The OD58 strain (provided by A. Audhya, University of California, San 
 Diego, La Jolla, CA) carries a PH membrane domain of phospholipase-C 
fused in-frame to a GFP reporter (unc119; pAAI pie-1::GFP-PH (PLC1δ1 
PH); unc-119) under the control of the pie-1 promoter (Audhya et al., 
2005). All other strains were obtained from the Caenorhabditis Genetics 
Center and cultivated as described previously (Brenner, 1974). Worm 
 vectors were provided by A. Fire (Stanford University School of Medicine, 
Stanford, CA).
In silico analysis
BLAST searches were performed in the National Center for  Biotech-
nology Information database (http://www.ncbi.nlm.nih.gov) or WormBase 
(http://wormbase.org) using annotated human or mouse CSPG core 
protein sequences. The presence of signal peptides was confi rmed with 
PSORT II (http://psort.hgc.jp/) and SignalP 3.0 Server (http://www.cbs.
dtu.dk/services/SignalP).
Biochemical purifi cation
Worm extracts were prepared from 20-g batches of a mixed-stage N2 
(Bristol) population by sonication in 50 mM sodium acetate buffer, pH 6. 
Material was extracted for 48 h at 4°C in three volumes of solution con-
taining 4 M guanidine-HCl, 0.1 M NaCl, 0.3% CHAPS, 50 mM sodium 
acetate, pH 6, and protease inhibitors (1 μg/ml leupeptin, 1 mM PMSF, 
and 1 μg/ml pepstatin A; Esko, 1993). The extract was dialyzed three 
times against 40 volumes of 6 M urea, 0.1 M NaCl, and 50 mM sodium 
acetate, pH 6. Insoluble material was removed by low-speed centrifugation 
and fi ltration through fi lter paper (No. 1; Whatman). The concentration of 
protein was assayed by the Bradford method (Bio-Rad Laboratories).
Proteoglycans were purifi ed from worm extract (250 mg protein) by 
anion-exchange chromatography (0.2 M – 1 M NaCl, DEAE-Sephacel) 
and desalted by gel fi ltration (Bame and Esko, 1989). Partially purifi ed 
material was treated with trypsin (Wolters et al., 2001), and glycopeptides 
were further purifi ed by an additional pass over DEAE-Sephacel and in some 
experiments by gel fi ltration HPLC (TSK-2000 column [Tosoh Bioscience]; 
1 M NaCl in 10 mM KH2PO4, pH 6). Fractions containing uronic acid 
(Esko and Manzi, 1996) were pooled and desalted by gel fi ltration. 
Glycosaminoglycan chains were removed by β-elimination followed by 
Michael addition with DTT (BEMAD; Wells et al., 2002). In brief, glycopep-
tides were incubated for 3 h at 50°C in 20% ethanol, 1% triethylamine, 10 mM 
DTT, and 0.1% NaOH. The reaction was quenched by adjusting the sam-
ple to 1% trifl uoroacetic acid, and the peptides were purifi ed by reverse-
phase chromatography on a C18 Sep-Pak cartridge (Waters Corporation) 
by elution with 70% acetonitrile in 0.1% trifl uoroacetic acid. Samples were 
dried before further analysis. In some experiments, the samples were 
passed over a thiol-Sepharose column to enrich for DTT-modifi ed peptides 
(Wells et al., 2002).
Mass spectrometry
Tagged peptides were identifi ed by MUDPIT (Washburn et al., 2001; 
 Wolters et al., 2001; MacCoss et al., 2002; Washburn et al., 2002). 
 Peptides were eluted stepwise from a biphasic capillary column made of 
strong cation-exchange resin coupled to a reverse-phase resin directly into 
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a tandem mass spectrometer. The identities of the DTT-tagged peptides 
were determined by searching the tandem mass spectra against a 
C.  elegans proteome database using SEQUEST software and a computer 
array. The unique mass signature imparted by DTT (+167 D) and unmodi-
fi ed  dehydroalanine residues (−18 D) were used to determine the sites of 
 chondroitin addition.
Recombinant protein expression
C. elegans cDNA was prepared from total RNA with the SuperScript III 
First-Strand kit (Invitrogen). cpg-1 through -9 were amplifi ed from 
C. elegans cDNA with primers that included the start codon and the pen-
ultimate codon and restriction sites to subclone the products in-frame into 
the pcDNA3.1(-)MycHis B vector (Invitrogen). Expression constructs were 
transfected into COS-7 cells with Lipofectamine (Invitrogen) following the 
manufacturer’s instructions. Media was harvested 48 h later and purifi ed 
over DEAE-Sephacel as described previously (Bame and Esko, 1989). 
COS-7 cells were cultured in Dulbecco’s modifi ed Eagle’s medium (CellGro) 
supplemented with 10% fetal bovine serum, 100 U/ml penicillin G, and 
100 μg/ml streptomycin sulfate.
RNAi
C. elegans cDNA was amplifi ed by PCR with primers engineered to con-
tain T7 (forward primer) or T3 (reverse primer) bacterial promoter sequence 
and base pairs 1–649 for cpg-1 and 1–775, 754–1572, and 1190–
1572 for cpg-2. dsRNA was generated with the Megascript T7 and T3 
transcription kits (Ambion) according to the manufacturer’s instructions. 
OD58 L4 or young adult worms were injected with dsRNA and allowed to 
recover at 16°C or 20°C. To count brood sizes, worms were transferred 
24 h after injection to individual plates, and 1 d later the number of eggs 
and hatched L1 larvae were counted (Maddox et al., 2005). Viability was 
measured 24–36 h later by counting the number of hatched larvae and un-
hatched embryos. Percentage of viability was calculated as number of 
hatched progeny divided by the total number of eggs laid.
Early embryonic cell division was assessed 24 h after injection. 
 Embryos were fi lmed in utero because cpg-1/cpg-2(RNAi) and sqv-5(RNAi) 
embryos were fragile and osmotically sensitive. Injected animals were 
anesthetized with 1 mM levamisole in M9 buffer, mounted on an agarose 
pad, and fi lmed as described previously (Maddox et al., 2005). Images 
were acquired on a DeltaVision deconvolution microscope (Applied 
 Precision) equipped with a charge-coupled device camera (CoolSnap; 
Roper Scientifi c) at 20°C. Images were acquired using a 100×, 1.3 NA 
U-Planapo objective (Olympus) with a 2 × 2 binning and a 480- × 480-
pixel area. DIC and GFP images were acquired at 10-s intervals by se-
quentially rotating the analyzer and GFP fi lter set into the light path. 
Illumination was attenuated with a 10% neutral density fi lter. Images were 
analyzed with MetaMorph software (Universal Imaging Corp.).
To determine the effect of RNAi on proteoglycan expression, cDNA 
sequences for cpg-1 and -2 described earlier in this section were sub-
cloned into vector pL4440, which carries dual T7 promoter sites (Fire Lab 
Vector kit) and drives the formation of dsRNA. The expression vector was 
transformed into the HT115 bacterial strain, which was then fed to L1 lar-
val worms as described previously (Kamath et al., 2001). After 48–60 h, 
protein extracts were prepared by sonication of either whole worms or em-
bryos and subjected to SDS-PAGE and Western blotting as described in the 
next section.
Chitin binding experiments were performed with chitin beads (New 
England Biolabs, Inc.) according to the manufacturer’s instructions. 
 Unbound protein (including the wash buffer) was desalted by gel fi ltration 
before analysis. Bound material was analyzed by boiling chitin beads in 
SDS buffer and loading the sample directly onto the gel.
Western blotting
Proteoglycan samples (10 μL) were digested with 10 mU chondroitinase 
ABC (Seikagaku) and/or 2.5 mU heparin lyase II (Sigma-Aldrich) for 3–5 h 
at 37°C. After reduction with β-mercaptoethanol and alkylation with iodo-
acetamide, samples were analyzed by SDS-PAGE. CPG core proteins were 
detected with 1B5 chondroitin stub mAb (1:1,000; Seikagaku) followed by 
goat anti–mouse secondary antibody (1:2,000; Bio-Rad Laboratories). 
 Recombinant proteins expressed in animal cells were Western blotted with 
a murine anti-Myc mAb (1:5,000; Invitrogen). Blots were visualized with the 
WestPico Chemiluminescent kit (Pierce Chemical Co.).
Online supplemental material
The videos show the fi rst two rounds of cell division in C. elegans em-
bryos exposed to the RNAi treatments described in Fig. 7. Video 1 shows 
normal cell division in buffer-injected embryos. Video 2 shows normal 
cell division in cpg-2(RNAi) embryos. Video 3 shows that cpg-1/cpg-
2(RNAi) embryos fail to complete the fi rst cell division. Video 4 shows 
that sqv-5(RNAi) produces the same phenotypic defects as cpg-1/cpg-
2(RNAi). Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200603003/DC1.
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